Mild cognitive impairment: what the diagnosis does — and doesn't — mean

MCI sits between normal aging and dementia. It is common, it doesn't always progress, and knowing the cause can open real options.

Written by Dr. Neelum Aggarwal, MD, cognitive neurologist Last reviewed Sources cited Editorial policy
Memory & diagnosis8 min readPublished Reviewed

Key takeaways

  • MCI means a measurable change in memory or thinking while daily life stays mostly independent.
  • Not everyone with MCI develops dementia; some people stay stable or improve.
  • Finding the cause matters, and newer blood tests are adding to the diagnostic toolkit.
  • Heart-healthy habits, activity and staying socially engaged are reasonable steps for everyone with MCI.

Hearing the words "mild cognitive impairment" can be unsettling. Many people leave the appointment wondering whether it is the first step toward Alzheimer's disease. The honest answer is: sometimes, but not always. Here is what the diagnosis means and what you can do with it.

What MCI is

MCI describes a decline in memory or other thinking skills that is greater than expected for a person's age and is noticeable on testing, while the person can still take care of everyday activities largely on their own. It is common. The Alzheimer's Association estimates that about 12% to 18% of people aged 60 or older are living with MCI[1].

Doctors sometimes describe two broad types. In amnestic MCI, memory is mainly affected. In non-amnestic MCI, other skills such as attention, language, planning or visual-spatial skills are more affected. The pattern gives clues about the likely cause.

Does MCI always lead to dementia?

No. An estimated 10% to 15% of people with MCI develop dementia each year, and some people with MCI stay stable or even return to normal thinking over time[1]. The outlook depends a great deal on what is causing the changes. MCI caused by early Alzheimer's disease behaves differently from MCI driven by poor sleep, depression or a medication side effect.

Finding the cause

A careful evaluation looks at the history, cognitive testing, exam, blood work and brain imaging[2]. When Alzheimer's disease is a possibility, biomarker tests can show whether the hallmark protein changes are present. These include an amyloid PET scan, a spinal-fluid test and, increasingly, blood tests.

Blood tests for Alzheimer's-related changes have moved quickly. In 2025 the Alzheimer's Association published its first clinical practice guideline on them. It says that in specialist memory care, for people who already have cognitive symptoms, blood tests that meet high accuracy thresholds can be used to help triage or confirm whether Alzheimer's pathology is present — as part of a full evaluation, not on their own[3]. Since 2025 the FDA has cleared several such tests for adults with symptoms, most recently in August 2026[4]. They are not meant for people without symptoms who are simply curious.

A blood test result is one piece of evidence. It is read alongside your history, your testing and your exam — never instead of them.

Why a clear diagnosis is worth having

  • Treatable contributors can be addressed, such as sleep apnea, depression, hearing loss or a medicine that dulls thinking.
  • Treatment options may open up. The newer anti-amyloid medicines are approved for people with MCI or mild dementia due to Alzheimer's disease, after testing confirms amyloid. They are not right for everyone; see our article on these treatments.
  • Planning becomes easier: finances, legal documents, driving and family conversations are easier to handle early.
  • Research becomes an option. Many studies specifically seek people with MCI.

Living well with MCI

There is no medicine approved specifically for MCI in general. But there are things worth doing. In the US POINTER trial, 2,111 older adults at risk of decline who followed a structured program of exercise, a brain-healthy diet, mental and social activity and health monitoring improved their cognition over two years slightly more than people following a self-guided version, although both groups improved[5]. Practical steps include:

  • Regular physical activity you enjoy and can keep up
  • Good control of blood pressure, blood sugar and cholesterol
  • Treating hearing loss and checking your vision
  • Protecting sleep and getting snoring or breathing pauses checked
  • Staying socially connected and mentally engaged
  • Routines, calendars and phone reminders to reduce day-to-day stress

Follow-up visits, often every 6 to 12 months, help track whether things are stable, improving or changing.

When to see a doctor

Ask for a follow-up evaluation if you've been told you have MCI and haven't discussed the likely cause, or if symptoms are getting worse. Seek urgent care for sudden changes in thinking, speech or alertness.

Sources

  1. Alzheimer's Association. Mild cognitive impairment (MCI). View source (opens in a new tab)
  2. Dickerson BC, Atri A, Clevenger C, et al. The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): executive summary of recommendations for specialty care. Alzheimers Dement. 2025;21(1):e14337. View source (opens in a new tab)
  3. Palmqvist S, Whitson HE, Allen LA, et al. Alzheimer's Association clinical practice guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings. Alzheimers Dement. 2025;21(7):e70535. View source (opens in a new tab)
  4. NeurologyLive. FDA clears Roche's single-biomarker Elecsys pTau217 blood test for Alzheimer disease. August 24, 2026. View source (opens in a new tab)
  5. Baker LD, Espeland MA, Whitmer RA, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial. JAMA. 2025;334(8):681-691. View source (opens in a new tab)
Written and reviewed by

Neelum T. Aggarwal, MD

Cognitive neurologist and clinical trialist; Professor of Neurological Sciences, Rush University Medical Center, Chicago.

How this article was written and reviewed

General education for adults and families, not personal medical advice. Opinions are Dr. Aggarwal's own and not those of Rush University Medical Center. In an emergency, call 911.

Q.

What should I read next?